Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
about
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive EarlyEvaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM StudyApproval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approvalThe Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.Oncology providers' perspectives on endocrine therapy prescribing and management.The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
P2860
Q30732631-E6325DB8-780D-4F13-A1D3-DFD46442D1CBQ34764981-5D379293-DE87-4FF5-B639-42C2A18799FFQ35642388-2DBDDCF8-D633-4689-BBB8-98D751D6AFF4Q35684410-87AA624D-A714-4294-9A7F-6521C7F3E86EQ37316792-F22CD6A7-1BC3-41AD-B760-28FF780F2866Q37706917-8EB92D5F-9F44-4823-97EF-C4BBBA9C40C6Q37794991-3FBF63E8-D1CA-4A94-8F4E-752E477B4F89Q55423368-7A9BA28B-B5C2-4BE2-BDB2-0A8C3DB2D02C
P2860
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@en
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@nl
type
label
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@en
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@nl
prefLabel
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@en
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@nl
P1476
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
@en
P2093
John H Ward
P356
10.1097/GCO.0B013E328334FF40
P577
2010-02-01T00:00:00Z